Page last updated: 2024-11-07

beta-phenylcysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Beta-phenylcysteine is a non-proteinogenic amino acid with a phenyl group at the beta position. It has been synthesized through various methods, including the Strecker reaction and the enzymatic reaction catalyzed by phenylalanine ammonia-lyase. Beta-phenylcysteine is a potential precursor for the synthesis of various bioactive compounds, including beta-lactams and beta-amino acids. Research on beta-phenylcysteine focuses on its potential applications in the development of new drugs and materials, particularly in the field of cancer treatment. Its unique structure and chemical properties make it an attractive target for pharmaceutical and material science applications. Beta-phenylcysteine exhibits various biological activities, including antibacterial, antifungal, and anticancer effects. These effects are attributed to its ability to interfere with the biosynthesis of essential cellular components or to induce apoptosis. The study of beta-phenylcysteine is ongoing, aiming to further understand its mechanisms of action and explore its potential therapeutic applications.'

Cross-References

ID SourceID
PubMed CID119462
CHEMBL ID63062
SCHEMBL ID342512
MeSH IDM0124758

Synonyms (24)

Synonym
s-phenyl-l-cysteine, 97%
34317-61-8
s-phenyl-l-cysteine
CHEMBL63062
(2r)-2-amino-3-phenylsulfanylpropanoic acid
AKOS007930134
AKOS006281414
(r)-2-amino-3-(phenylthio)propanoic acid
A822168
l-cysteine, s-phenyl-
beta-phenylcysteine
SCHEMBL342512
J-700245
XYUBQWNJDIAEES-QMMMGPOBSA-N
FD21309
mfcd01318758
DTXSID20187882
AC-10075
(2r)-2-ammonio-3-(phenylthio)propanoate
h-cys(phenyl)-oh
AS-49032
CS-0033656
(r)-2-amino-3-(phenylthio)propanoicacid
l-s-phenylcysteine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" We were able to detect SPC in the hemoglobin of exposed rats and mice, to show the linearity of the exposure dose-response relationship, and to establish the sensitivity limits of this assay."( S-phenylcysteine formation in hemoglobin as a biological exposure index to benzene.
Bechtold, WE; Birnbaum, LS; Henderson, RF; Kasicki, S; Li, GL; Lucier, G; Sun, JD; Yin, SN, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID44227Specific activity against beta-elimination reaction by rat renal cytosolic beta-lyase after incubation with 0.2 mg of protein/mL for 10 min at 37 degree C using 1 mM substrate conc.1996Journal of medicinal chemistry, May-10, Volume: 39, Issue:10
Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of beta-elimination reactions in rat renal cytosol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's5 (50.00)18.2507
2000's1 (10.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.26 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]